Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Atrophy, Muscle

3,3',5-triiodothyroacetic acid has been researched along with Atrophy, Muscle in 4 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
van Geest, FS1
Groeneweg, S1
van den Akker, ELT1
Bacos, I1
Barca, D1
van den Berg, SAA1
Bertini, E1
Brunner, D1
Brunetti-Pierri, N1
Cappa, M1
Cappuccio, G1
Chatterjee, K1
Chesover, AD1
Christian, P1
Coutant, R1
Craiu, D1
Crock, P1
Dewey, C1
Dica, A1
Dimitri, P1
Dubey, R1
Enderli, A1
Fairchild, J1
Gallichan, J1
Garibaldi, LR1
George, B1
Hackenberg, A1
Heinrich, B1
Huynh, T1
Kłosowska, A1
Lawson-Yuen, A1
Linder-Lucht, M1
Lyons, G1
Monti Lora, F1
Moran, C1
Müller, KE1
Paone, L1
Paul, PG1
Polak, M1
Porta, F1
Reinauer, C1
de Rijke, YB1
Seckold, R1
Menevşe, TS1
Simm, P1
Simon, A1
Spada, M1
Stoupa, A1
Szeifert, L1
Tonduti, D1
van Toor, H1
Turan, S1
Vanderniet, J1
de Waart, M1
van der Wal, R1
van der Walt, A1
van Wermeskerken, AM1
Wierzba, J1
Zibordi, F1
Zung, A1
Peeters, RP2
Visser, WE2
Bauer, AJ1
Kersseboom, S1
Horn, S1
Chen, J1
Friesema, EC1
Vaurs-Barrière, C1
Heuer, H1
Visser, TJ1
Krude, H1
Kühnen, P1
Biebermann, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency Also Known as Allan-Herndon-Dudley Syndrome (AHDS)[NCT05911399]0 participants Expanded AccessAvailable
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for 3,3',5-triiodothyroacetic acid and Atrophy, Muscle

ArticleYear
Treatment of congenital thyroid dysfunction: Achievements and challenges.
    Best practice & research. Clinical endocrinology & metabolism, 2015, Volume: 29, Issue:3

    Topics: Congenital Hypothyroidism; Hormone Replacement Therapy; Humans; Hydrolases; Infant, Newborn; Iodide

2015

Other Studies

3 other studies available for 3,3',5-triiodothyroacetic acid and Atrophy, Muscle

ArticleYear
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study.
    The Journal of clinical endocrinology and metabolism, 2022, 02-17, Volume: 107, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; M

2022
Triac in the treatment of Allan-Herndon-Dudley syndrome.
    The lancet. Diabetes & endocrinology, 2019, Volume: 7, Issue:9

    Topics: Adult; Child; Humans; Mental Retardation, X-Linked; Muscle Hypotonia; Muscular Atrophy; Triiodothyro

2019
In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
    Molecular endocrinology (Baltimore, Md.), 2014, Volume: 28, Issue:12

    Topics: Animals; Biological Transport; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Chlorocebus

2014